Screener
Ligand Pharmaceuticals LGND Net debt
Discontinued — last reported Q2 '26
Net debt at other companies
Other financials
Where this comes from
Calculated from Ligand Pharmaceuticals’s reported figures.
The source filing: Ligand Pharmaceuticals’s 10-Q, filed August 7, 2026. Open the filing →
- Filed
- Aug 7, 2026, 4:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000886163-26-000044
FAQ
- What is Ligand Pharmaceuticals's net debt?
- Ligand Pharmaceuticals (LGND) reported net debt of $124.75M in Q2 2026.
- How has Ligand Pharmaceuticals's net debt changed year-over-year?
- Ligand Pharmaceuticals's net debt increased by 301.4% year-over-year, from -$61.93M to $124.75M.
- What is the long-term trend for Ligand Pharmaceuticals's net debt?
- Over 5 years (2020 to 2025), Ligand Pharmaceuticals's net debt has grown at a 44.3% compound annual growth rate (CAGR), from -$27.14M to -$169.58M.
- What does net debt mean?
- Total debt minus cash and equivalents at the quarter end. The debt that would remain if the company used all its cash to pay down borrowings.
Ask your AI about Ligand Pharmaceuticals's net debt.
Connect your AI assistant and see it in context, right in your chat.
Connect your AI
Claude